From this article in the British Medical Journal, it sounds like AstraZeneca's announcement that it will no longer pay for doctors to attend international conferences was part of a larger movement toward rethinking physician/industry relationships in Europe.
Key quote: “'I think sunshine in Europe is both desirable and inevitable,' says Richard Bergstrom, head of the European Federation of Pharmaceutical Industries and Associations, the Brussels based industry trade body that represents companies across the EU. But he stresses the need to take into account the varied approaches and interactions between doctors and companies in different countries."
0 comments
Hide comments
